Literature DB >> 4026310

Oligosaccharide chains of herpes simplex virus type 2 glycoprotein gG.2.

F Serafini-Cessi, N Malagolini, F Dall'Olio, L Pereira, G Campadelli-Fiume.   

Abstract

gG.2 glycoprotein was purified by H966 monoclonal antibodies linked to Sepharose from herpes simplex virus type 2-infected HEp-2 cells labeled with [3H] glucosamine. The glycoprotein was subjected to Pronase digestion and the glycopeptides were fractionated by Con A-Sepharose in a major fraction (88.5% of total radioactivity) unbound to the lectin gel and in a minor species which bound to the lectin as a N-linked diantennary oligosaccharide. Mild and strong acid hydrolysis of Con A-unbound and Con A-bound fractions revealed that (i) both species were highly sialylated; (ii) the Con A-unbound fraction contained mainly labeled N-acetylgalactosamine, as is the case for O-linked oligosaccharides; and (iii) the Con A-bound fraction carried the vast majority of the labeled N-acetylglucosamine present in gG.2. Three size classes of oligosaccharides were separated from mild alkaline borohydride-treated Con A-unbound glycopeptides, which accounted for about 80% of the radioactivity present in the fraction. Galactosaminitol was recovered as the major labeled product in the strong acid hydrolyzates of the oligosaccharides generated by reductive beta-elimination, indicating that they were O-glycosidically linked to the peptide backbone. Thin-layer and DEAE-Sephacel chromatography of the three O-linked oligosaccharide species indicated that disialylated tetrasaccharides and monosialylated trisaccharides were the major components, whereas neutral disaccharide was a minor component. Digestion with neuraminidase and beta-galactosidase of the O-linked oligosaccharides supported the idea that the common disaccharide core was mainly of the structure beta-galactosyl-N-acetylgalactosamine. The large occurrence of O-linked oligosaccharides differentiates this type 2-specific herpes simplex virus glycoprotein from the type-common herpesvirus glycoproteins gB, gC, and gD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026310     DOI: 10.1016/0003-9861(85)90097-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Differentiation-dependent glycosylation of gp190, an oncofetal crypt cell antigen expressed by Caco-2 cells.

Authors:  N Malagolini; D Cavallone; F Serafini-Cessi
Journal:  Glycoconj J       Date:  2000-05       Impact factor: 2.916

2.  Temporal aspects of O-glycosylation of glycoprotein C from herpes simplex virus type-1.

Authors:  F Serafini-Cessi; F Dall'Olio; N Malagolini; G Campadelli-Fiume
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

3.  Glycosylation pattern of herpes simplex virus type 2 glycoprotein G from precursor species to the mature form.

Authors:  F Dall'Olio; N Malagolini; G Campadelli-Fiume; F Serafini-Cessi
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Fragmentation and dispersal of Golgi proteins and redistribution of glycoproteins and glycolipids processed through the Golgi apparatus after infection with herpes simplex virus 1.

Authors:  G Campadelli; R Brandimarti; C Di Lazzaro; P L Ward; B Roizman; M R Torrisi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  The herpes simplex virus UL20 protein compensates for the differential disruption of exocytosis of virions and viral membrane glycoproteins associated with fragmentation of the Golgi apparatus.

Authors:  E Avitabile; P L Ward; C Di Lazzaro; M R Torrisi; B Roizman; G Campadelli-Fiume
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  A soluble form of Sda-beta 1,4-N-acetylgalactosaminyltransferase is released by differentiated human colon carcinoma CaCo-2 cells.

Authors:  F Serafini-Cessi; N Malagolini; S Guerrini; I Turrini
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

7.  Identification and characterization of the Sda beta 1,4,N-acetylgalactosaminyltransferase from pig large intestine.

Authors:  N Malagolini; F Dall'Olio; S Guerrini; F Serafini-Cessi
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

Review 8.  Inhibitors of protein glycosylation and glycoprotein processing in viral systems.

Authors:  R Datema; S Olofsson; P A Romero
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

9.  Global aspects of viral glycosylation.

Authors:  Ieva Bagdonaite; Hans H Wandall
Journal:  Glycobiology       Date:  2018-07-01       Impact factor: 4.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.